Dr. Loh received her B.Sc. (Hons.) in Biochemistry from University College Dublin, Ireland, and her Ph.D. in Molecular Biology from the University of Pennsylvania. She did her postdoctoral work with Dr. Harold Gainer at NIH and at the Max Planck Institute in Germany.

During her career at NIH, Dr. Loh has received numerous honors and awards including the Public Health Superior Service Award, the NIH Director’s Award, the NIH Director’s Award for Mentoring, the FASEB Award for Excellence in Science, and the Women in Endocrinology Mentor Award.

She is a member of the Endocrine Society, Society for Neuroscience, serves on several editorial boards and is the Editor-in-Chief of the journal Extracellular Vesicles and Circulating Nuclear Acids.

Her studies have elucidated molecular mechanisms governing protein trafficking to the regulated secretory pathway and identified players and mechanisms that control secretory granule biogenesis and transport in endocrine and neuroendocrine cells and neurons. She and her team discovered novel neurotrophic roles of CPE in neuroprotection and stem cell differentiation. Most notably she has shown that CPE ( also known as Neurotrophic factor-alpha1) can protect hippocampal neurons against stress-induced cell death and is more critical than BDNF. Most recently, she and her group demonstrated that injection of adeno-associated virus carrying the CPE gene (AAV-CPE) into the hippocampus of Alzheimer Disease (AD) mouse models , pre- symptomatically and post-symptomatically, prevented /rescued memory loss, amyloidosis, neurodegeneration, all hallmarks of AD. She is currently translating her findings to developing AAV-CPE gene therapy and small molecules as approaches to treat AD and mild traumatic brain injury. Her research has also provided a better understanding of diseases such as diabetes, obesity, depression and dementia. Her group has also cloned a splice variant of CPE encoding a 40kD N-terminal truncated isoform (CPE-deltaN) that is highly expressed in embryonic brain and is involved in neuronal proliferation and migration. It is also expressed in different types of metastatic tumor cells and is an inducer of tumor growth and metastasis. Clinical studies have shown that CPE-∆N is a promising prognostic biomarker for predicting future metastasis, and a potential therapeutic target for different malignant cancers.

She has authored more than 200 scientific articles published in journals such as Cell, Nature Medicine, Journal of Clinical Investigations, JAMA, Neuron, the Proceedings of the National Academy of Science and Molecular Psychiatry, as well as published numerous review articles and a book.